Faculty Disclosure Index DDW Sponsoring Society CME Statements
Total Page:16
File Type:pdf, Size:1020Kb
Faculty Disclosure Index DDW Sponsoring Society CME Statements Disclosure Requirements for DDW 2021 AASLD CME Statement The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AASLD designates this other activity (internet live meeting and internet enduring material) for a maximum of 46.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AASLD Statement on Disclosure It is the policy of AASLD to ensure balance, independence, objectivity and scientific rigor in all its individually and jointly provided educational activities. All faculty/authors participating in any AASLD provided programs, as well as planners and committee members, are expected to fully disclose all financial relationships with a commercial interest during the past 12 months. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the speaker shall disclose to the audience that the product is not labeled for the use under discussion or that the product is still investigational. AASLD will identify and resolve all conflicts of interest prior to program implementation. AGA Institute CME Statement The American Gastroenterological Association Institute (AGA Institute) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AGA Institute designates this other activity (internet live meeting and internet enduring material) for a maximum of 229.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. ASGE CME Statement The American Society for Gastrointestinal Endoscopy (ASGE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASGE designates this other activity (internet live meeting and internet enduring material) for a maximum of 100.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ASGE requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial entity producing health-care related products and/or services. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through the ASGE Conflict of Interest Resolution Policy Process. All disclosures are made available and communicated to the learner prior to the activity starting. SSAT CME Statement In support of improving patient care, this activity has been planned and implemented by Cine-Med and the Society for Surgery of the Alimentary Tract (SSAT). Cine-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Ciné-Med designates this other activity (internet live meeting and internet enduring material) for a maximum of 45.0 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. All other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for activities designated for AMA PRA Category 1 Credits™, consult your professional licensing board. Disclosure Legend 1 The speaker does not have any relevant financial or other relationship with manufacturer(s) or provider(s) of commercial products or services that they will discuss during the presentation 2 The speaker does HAVE a relevant financial or other relationship with manufacturer(s) or provider(s) of commercial products or services that they will discuss during the presentation 3 No financial disclosure information provided Last Name First Name Response Financial Disclosure Alvares‐da‐Silva Mario 1 Aabakken Lars 1 Aadam A. Aziz 2 Boston Scientific: Consulting; Steris Endoscopy: Consulting Aagaard Eva 1 Aakash N 1 Aardema Charles 3 Aardoom Martine 1 Aaron Bailey 1 Abadir Alexander 1 Abasszade Joshua 1 Abaza Ehab 1 Abbarh Shahem 1 Abbas Ali 1 Abbas‐Egbariya Haya 1 Abbass Ibrahim 2 Genentech: Employment Abbou Lisa 1 Abboud Yazan 1 Abdala‐Valencia Hiam 3 Abdallah Mohamed 1 Abdelfatah Magdy Mohamed 1 Abdelfattah Ahmed 1 Abdelhafez Mohamed 1 Abdelmasseh Michael 1 Abdelqader Abdelhai 1 Abdo Juan Miguel 1 Abdul Razzack Aminah 1 Abdul‐Baki Heitham 1 Abdulhamid Ahmed 1 Abdulkerim Hassen 1 Abdulkhakov Sayar 1 Abdulkhakov Rustem 1 AbdulMujeeb Sufyan 1 Abe Seiichiro 2 Boston Scientific: Consulting; FUJIFILM: Grant/Research Support; Olympus: Grant/Research Support Abe Yasuhiko 1 Abe Hiroko 1 Abe Takashi 1 1 DDW 2021 Financial Disclosure Index Last Name First Name Response Financial Disclosure Abell Thomas 2 ADEPT‐GI: Patent Held/Filed; Allergan: Grant/Research Support; Censa: Consulting, Grant/Research Support; Cindome: Grant/Research Support; MedStudy: Independent Contractor; Medtronic: Speaking and Teaching; Neurosatrix: Grant/Research Support; Nuvaira: Consulting; Takeda: Consulting, Speaking and Teaching; UpToDate: Consulting; Vanda: Grant/Research Support Aberle Merel R. 1 Abichandani Sonia 1 Abi‐Hanna David 1 Abilash Vijay 2 Takeda: Consulting Abitbol Vered 1 Abnet Christian 1 Abohelwa Mostafa 1 Abood Gerard 1 Abou Saleh Mohannad 1 Abou Yassine Ahmad 1 Aboubakr Aiya 1 Aboud Syriani Lara 1 Abougergi Marwan 1 Abraham Bincy 2 Abbvie: Consulting, Speaking and Teaching; Ferring: Consulting; Janssen: Consulting, Speaking and Teaching; Lilly: Consulting; Medtronic: Consulting; Pfizer: Consulting; Samsung bioepis: Consulting; Takeda: Consulting Abraham Fiyinfoluwa 1 Abraham George 1 Abraham Mathew 1 Abraham Clara 1 Abrahao Luiz 1 Abraldes Juan 1 Abrams Julian 2 Exact Sciences: Advisory Committees or Review Panels Abrams Hannah 3 Abrams Daniela 1 Abrams Eric 1 Abramson Lior 1 Abrenica Cristoniel 1 2 DDW 2021 Financial Disclosure Index Last Name First Name Response Financial Disclosure Abreu Maria 2 AbbVie Inc: Consulting; Boehringer Ingelheim: Advisory Committees or Review Panels; Cornerstones Health, Inc: Consulting; Cosmo Pharmaceuticals: Advisory Committees or Review Panels; Eli Lilly Pharmaceuticals: Consulting; Focus Medical Communications: Consulting; Gilead: Advisory Committees or Review Panels; Imedex: Consulting; Janssen Pharmaceuticals: Advisory Committees or Review Panels; Pfizer: Grant/Research Support; Prometheus Biosciences: Consulting; Prometheus Laboratories Inc.: Grant/Research Support; Takeda Pharmaceuticals, Inc.: Grant/Research Support; UCB Biopharma SRL: Advisory Committees or Review Panels Abrol Robinder 1 Absah Imad 1 Abu Dayyeh Barham 2 Apollo Endosurgery: Grant/Research Support; BFKW: Consulting; Boston Scientific: Consulting; DyaMx: Consulting; Endogastric Solutions: Speaking and Teaching; Hemostasis: Consulting; Johnson and Johnson: Consulting; Medtronic: Grant/Research Support; USGI: Grant/Research Support Abu Ghanimeh Mouhanna 1 Abu Omar Yazan 1 Abu‐El‐Haija Maisam 1 Abuhelwa Ziad 1 Aburayyan Kanana 1 Abureesh Mohammad 1 Abusaleh Rami 1 Abusalih Mohamed 1 Abusalim Abdul‐Rahman 1 Abu‐Sbeih Hamzah 1 Abutaleb Ameer 1 Aby Elizabeth 1 Accarie Alison 1 Acevedo Lisette 2 Arena Pharmaceuticals: Employment Aceves Seema 2 AImmune: Consulting; DBV: Consulting; Regeneron: Consulting; Takeda (UCSD patent): Other Activities Not in List 3 DDW 2021 Financial Disclosure Index Last Name First Name Response Financial Disclosure Aceves Seema 2 AImmune: Consulting; DBV: Consulting; Regeneron: Consulting; Takeda (UCSD patent): Other Activities Not in List Acharjee Animesh 1 Acharya Ashu 1 Acharya Chathur 1 Achebe Ikechukwu 1 Achem Sami 1 Acherman Yair 1 Achkar Jean‐Paul 1 Achrafie Lia 2 Amaris Consulting: Consulting Acosta Andres 2 Gila Therapeutics: Stock Shareholder; Phenomix Sciences: Stock Shareholder Acosta Camilo 1 Acra Sari 1 Adam Atif 1 Adamos Timothy 1 Adams Megan 1 Adams Christopher 2 STATinMED: Employee of STATinMED Research, a paid consultant to Janssen Scientific Affairs. Addasi Yazan 1 Addrizzo‐Harris Doreen 1 Adedokun Omoniyi 2 Janssen R&D: Employment; Johnson and Johnson: Stock Shareholder Adeleye Folake 1 Adenote Abimbola 1 Adib‐Tezer Hanan 1 Adigopula Bhargavi 1 Adkins Christopher 1 Adler Douglas 2 Abbvie: Consulting; BSC: Consulting; Merit: Consulting; Olympus: Consulting Adler Jeremy 2 Janssen Pharmaceuticals: Grant/Research Support Adler Emerald 1 Adnan Darbaz 1 Adoor Dayyan 1 Adorno William 1 Adorno Carlos 1 Adsul Shashi 2 Takeda Pharmaceuticals International AG: Employment, Employment Aduli Farshad 1 Aelvoet Arthur 1 4 DDW 2021 Financial Disclosure Index Last Name First Name Response